Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq Rules [Yahoo! Finance]
Aditxt, Inc. (ADTX)
Company Research
Source: Yahoo! Finance
discovering, developing, and deploying promising health innovations, today announced that it has entered into securities purchase agreements for the purchase and sale of an aggregate of 4,186 shares of the Company's Series C-1 Convertible Preferred Stock, 4,186 shares of the Company's D-1 Preferred Stock, and warrants to purchase approximately 1.65 million shares of common stock in a private placement priced at-the-market under Nasdaq rules. The shares of Series C-1 Convertible Preferred Stock have a stated value of $1,000 per share. They are initially convertible into an aggregate of approximately 1.65 million shares of common stock at a conversion price of $2.47 per share. The Series D-1 Preferred Stock permits the holders thereof to vote together with the holders of the Company's common stock on proposals to effectuate an increase in the shares of common stock that the Company is authorized to issue. The warrants will be exercisable commencing six months following the initial iss
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Evofem Biosciences Announces Financial Results for the First Quarter of 2024PR Newswire
- Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesBusiness Wire
- Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co. [Yahoo! Finance]Yahoo! Finance
- Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co. [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Aditxt signs agreement to acquire Appili Therapeutics [Seeking Alpha]Seeking Alpha
ADTX
Sec Filings
- 5/15/24 - Form NT
- 5/14/24 - Form S-1/A
- 5/13/24 - Form 8-K
- ADTX's page on the SEC website